Department of Pediatrics, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
J Thromb Haemost. 2024 Dec;22(12):3473-3478. doi: 10.1016/j.jtha.2024.08.017. Epub 2024 Sep 11.
Interpretation of coagulation testing in neonates currently relies on reference intervals (RIs) defined from older patient cohorts. Direct RI studies are difficult, but indirect estimation may allow us to infer normative neonatal distributions from routinely collected clinical data.
Assess the utility of indirect reference interval methods in estimating coagulation reference intervals in critically ill neonates.
We analyzed first-in-life coagulation testing results from all patients admitted to a level IV neonatal intensive care unit between January 1, 2018, and January 1, 2024. Results obtained after transfusion of any blood product were excluded. Indirect RIs were estimated across gestational age groups using refineR and compared with currently reported intervals for patients less than 1 year of age.
Prothrombin times (PTs) and international normalized ratios (INRs) were available for 1128 neonates, while activated partial thromboplastin times (APTTs) were available for 790 neonates. The indirect RI was 10 to 25 seconds in preterm, 10 to 22 seconds in term, and 10 to 24 seconds in all neonates for PT; 0.7 to 2.1 in preterm, 0.8 to 1.8 in term, and 0.8 to 1.9 in all neonates for INR; and 25 to 68 seconds in preterm, 25 to 58 seconds in term, and 25 to 62 seconds in all neonates for APTT. Compared with our current intervals, the indirect RIs would flag 58% fewer PT, 43% fewer INR, and 17% fewer APTT results as abnormal.
Indirectly estimated RIs in neonates admitted to intensive care show substantial divergence from current, first-year-of-life RIs, leading to an abundance of abnormal flags. The associations between these flags and provider behavior, transfusion practice, or clinical outcomes are areas of future exploration.
目前,新生儿凝血检测结果的解读依赖于从年龄较大的患者队列中定义的参考区间(RI)。直接 RI 研究较为困难,但间接估计可能使我们能够从常规收集的临床数据中推断出正常新生儿的分布。
评估间接参考区间方法在估计危重新生儿凝血参考区间中的效用。
我们分析了 2018 年 1 月 1 日至 2024 年 1 月 1 日期间入住四级新生儿重症监护病房的所有患者的首次生命凝血检测结果。排除了输注任何血液制品后的结果。使用 refineR 估计了各胎龄组的间接 RI,并与目前小于 1 岁患者的报告区间进行了比较。
1128 例新生儿的凝血酶原时间(PT)和国际标准化比值(INR)可用,790 例新生儿的活化部分凝血活酶时间(APTT)可用。间接 RI 为早产儿 10 至 25 秒,足月儿 10 至 22 秒,所有新生儿 10 至 24 秒;早产儿 0.7 至 2.1,足月儿 0.8 至 1.8,所有新生儿 0.8 至 1.9;早产儿 25 至 68 秒,足月儿 25 至 58 秒,所有新生儿 25 至 62 秒。与我们目前的区间相比,间接 RI 将标记为异常的 PT 减少 58%,INR 减少 43%,APTT 减少 17%。
入住重症监护病房的新生儿间接估计的 RI 与当前、生命第一年的 RI 存在显著差异,导致大量异常标志。这些标志与提供者行为、输血实践或临床结果之间的关系是未来探索的领域。